Introduction
Greg Moss, Chief Corporate Strategy and Legal Officer at Evommune discusses the steps in developing a biopharma startup’s business strategy and landscape. He reviews the power of building scientific vs. non-scientific teams and how they can influence a startup's culture, investor relations, and even approach to inevitable successes and failures. Moss also shares valuable insights into how Evommune is bringing immunology to the forefront by improving patients' lives beyond their symptoms.
